The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Andrew Teschendorff, Professor at the Chinese Academy of Sciences, is developing computational systems-biological tools to ...

A recent study suggests that a simple blood test measuring epigenetic aging could help predict breast cancer risk in older ...

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

Cancer is nothing but an uncontrolled growth of abnormal cells, which can affect any organ. This growth is the result of mutations developing in genes involved in growth regulation and/or DNA repair ...

Excessive alcohol consumption is the third-leading preventable cause of cancer in the U.S., linked to 100,000 cancer cases ...

New research suggests that firstborn twins may have a greater risk of developing leukemia than second-born twins.

DURECT Corporation (Nasdaq: DRRX) today announced the publication of a peer-reviewed article on the AHFIRM trial data in NEJM ...

I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

Researchers discovered a molecular timer that gets activated in the first days of pregnancy and influences when mice give ...

FROM weather forecast, healthcare, agriculture, science discovery to education, Alibaba’s AI Innovations aim to bring ...

Thermo Fisher Scientific, Horizon Discovery, OriGene Technologies, QIAGEN, and GeneCopoeia Lead the Competition MicroRNA ...